½ÃÀ庸°í¼­
»óǰÄÚµå
1494780

¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå ¿¹Ãø : Á¦Ç°º°, Àç·áº°, °íÁ¤º°, µðÀÚÀκ°, ¿¬·ÉÃþº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2030³â)

Digit Joint Implants Market Forecasts to 2030 - Global Analysis By Product, Material, Fixation, Design, Age Group, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀåÀº 2024³â¿¡ 7,238¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2030³â¿¡´Â 1¾ï 2,409¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 9.4%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

Áö°üÀý ÀÓÇöõÆ®´Â ¼Õ»ó ¶Ç´Â ±â´É Àå¾Ö¿¡ ºüÁø ¼Õ°¡¶ô °üÀýÀ» ´ëüÇϰųª º¸°­ÇÏ´Â µ¥ »ç¿ëµÇ´Â º¸Ã¶ µµ±¸ÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î ±Ý¼Ó°ú ¼¼¶ó¹Í°ú °°Àº ³»±¸¼ºÀÖ´Â Àç·á·Î ±¸¼ºµÈ ÀÌ·¯ÇÑ ÀÓÇöõÆ®´Â ÀÚ¿¬ °üÀýÀÇ ±¸Á¶¿Í ±â´ÉÀ» ¸ð¹æÇÏ¿© ȯºÎÀÇ ¼Õ°¡¶ôÀÇ À̵¿¼º°ú ±â´É¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¼Õ°¡¶ôÀÇ ¿òÁ÷ÀÌ´Â ¿µ¿ª°ú ¾ÈÁ¤¼ºÀ» ȸº¹½ÃÅ´À¸·Î½á, Áö°üÀý ÀÓÇöõÆ®´Â ¼Õ ±â´ÉÀÌ ÀúÇÏµÈ »ç¶÷ÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ã۰í ÀÏ»ó »ýȰ Ȱµ¿À» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

2022³â 5¿ù¿¡ NCBI°¡ °»½ÅÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, º¯Çü¼º °üÀýÁõÀº ¼¼°è Àα¸ÀÇ ¾à 3.3-3.6%°¡ ÀÌȯµÇ°í ÀÖÀ¸¸ç, 4,300¸¸¸íÀÌ Áߵ¿¡¼­ ÁßÁõÀÇ Àå¾Ö¸¦ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

¿Ü»ó¼º ºÎ»ó Áõ°¡

»ç°í, ½ºÆ÷Ã÷ °ü·Ã »ç°í, Á÷¾÷ À§Çè µîÀ¸·Î ÀÎÇÑ ¿Ü»óÀº Á¾Á¾ ¼Õ°¡¶ô °üÀýÀÇ ½É°¢ÇÑ ¼Õ»óÀ» ÃÊ·¡ÇÏ°í ±â´É ȸº¹À» À§ÇÑ ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù. Áö°üÀý ÀÓÇöõÆ®´Â ¼Õ»óµÈ °üÀýÀ» ´ëüÇϰųª ¼ö¸®ÇÔÀ¸·Î½á ½ÇÇà °¡´ÉÇÑ ÇØ°áÃ¥À» Á¦°øÇÏ¿© ȯÀÚ°¡ À̵¿¼º°ú ¼Õ½¬¿òÀ» µÇãÀ» ¼ö ÀÖ½À´Ï´Ù. ¿Ü»óÀ¸·Î ÀÎÇÑ ¼Õ»óÀÌ ²÷ÀÌÁö ¾Ê±â ¶§¹®¿¡ Áö°üÀý ÀÓÇöõÆ® ¼ö¿ä°¡ Áõ°¡ÇÏ°í ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÕº´ÁõÀÇ À§Çè

Áö°üÀý ÀÓÇöõÆ®¿¡¼­ ÇÕº´ÁõÀÇ À§ÇèÀº °¨¿°, ÀÓÇöõÆ® °áÇÔ, ½Å°æ ¼Õ»ó µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÇÕº´ÁõÀº ȸº¹ ±â°£ÀÇ Àå±âÈ­, Ãß°¡ ¼ö¼ú, ȯÀÚ ¸¸Á·µµ °¨¼Ò·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °á°ú´Â ÇコÄÉ¾î ºñ¿ëÀ» Áõ°¡½Ãų »Ó¸¸ ¾Æ´Ï¶ó ¼ö¼ú ¹× ÀÓÇöõÆ® ÀåÄ¡¿¡ ´ëÇÑ È¯ÀÚÀÇ ½Å·Ú¸¦ ¼Õ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ȯÀÚ´Â ´ëü Ä¡·á¸¦ ¼±ÅÃÇϰųª ÀÇ·á °³ÀÔÀ» ¿ä±¸ÇÏ´Â °ÍÀ» ¿ÏÀüÈ÷ Áö¿¬½Ãų ¼ö ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÕ´Ï´Ù.

Àç·á °úÇÐÀÇ ²÷ÀÓ¾ø´Â Çõ½Å

Àç·á °úÇÐÀÇ ²÷ÀÓ¾ø´Â Çõ½ÅÀº Áö°üÀý ÀÓÇöõÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. »ýüÀûÇÕ¼º ±Ý¼Ó, ¼¼¶ó¹Í, »ýºÐÇØ¼º Æú¸®¸Ó µîÀÇ Àç·áÀÇ Áøº¸¿¡ ÀÇÇØ ³»±¸¼º, »ýüÀûÇÕ¼º, ±â´É¼ºÀÌ °­È­µÈ ÀÓÇöõÆ®°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ» ÅëÇØ ¿Ü°úÀÇ»ç´Â °ñÀý °üÀý Àå¾Ö ȯÀÚ¿¡°Ô È¿°úÀûÀÎ Ä¡·á¹ýÀ» Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾î ¼ö¼ú ¼ºÀû°ú ȯÀÚ ¸¸Á·µµÀÇ Çâ»óÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç·á°úÇÐÀÇ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·ÂÀº Â÷¼¼´ë ÀÓÇöõÆ®ÀÇ Ã¢ÃâÀ» È®½ÇÈ÷ Çϰí Á¦Ç°Á¦°ø°ú Ä¡·áÈ¿°úÀÇ °³¼±À» ÅëÇØ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

´ëü Ä¡·á ¿É¼Ç

Áö°üÀý ÀÓÇöõÆ®¸¦ ´ëüÇÏ´Â Ä¡·á¹ýÀ¸·Î´Â ¹°¸®Ä¡·á, ÅëÁõ °ü¸®, »ýȰ ½À°ü °³¼±°ú °°Àº ºñ ¼ö¼úÀû Á¢±ÙÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´ëü ¿ä¹ýÀº ÀϽÃÀûÀÎ ¿ÏÈ­¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖÁö¸¸, ±Ùº»ÀûÀÎ °üÀý ¼Õ»ó¿¡ È¿°úÀûÀ¸·Î ´ëóÇÏÁö ¸øÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ±× °á°ú, ȯÀÚ´Â ¼ö¼úÀ» ´ÊÃ߰ųª ¿ÏÀüÈ÷ ÇÇÇÒ ¼ö ÀÖ°Ô µÇ°í, Áö°üÀý ÀÓÇöõÆ® ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀûÀÎ ¹æ¹ýÀ» ¼±È£Çϴ ȯÀÚ´Â ¿Ü°úÀû °³ÀÔÀ» °í·ÁÇÏ´Â °ÍÀ» ¸Á¼³ÀÌ°í ½ÃÀåÀÇ ÀáÀç·ÂÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ À¯ÇàÀº Áö°üÀý ÀÓÇöõÆ® ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¼ö¼ú ¿¬±â ¹× ÇコÄÉ¾î ¿ä±¸¿¡ ´ëÇÑ ÀǽÄÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àΰø °üÀý ´ëü¼úÀ» Æ÷ÇÔÇÑ Á¤Çü¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ´Â ¹Ý¸é °ø±Þ¸ÁÀÇ È¥¶õ°ú ÀÇ·á ½Ã¼³ Á¢±Ù¿¡ ´ëÇÑ ¾î·Á¿òµµ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ °æÁ¦ ºÒÈ®½Ç¼º°ú ÇコÄÉ¾î ¿ì¼±¼øÀ§ º¯È­´Â ȯÀÚÀÇ ÀÇ»ç°áÁ¤°ú ÇコÄɾî ÁöÃâ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªÇп¡ º¯È­¸¦ °æÇèÇϰí, ÆÒµ¥¹Í¿¡ ±âÀÎÇÏ´Â ±àÁ¤ÀûÀÌ°í ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹Þ½À´Ï´Ù.

¿¹Ãø±â°£ µ¿¾È »ýºÐÇØ¼º ÀÓÇöõÆ® ºÐ¾ß°¡ ÃÖ´ëÈ­µÉ Àü¸Á

»ýºÐÇØ¼º ÀÓÇöõÆ® ºÎ¹®Àº À¯¸®ÇÑ ¼ºÀåÀ» ÀÌ·ç´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. »ýºÐÇØ¼º ÀÓÇöõÆ®´Â ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ü³»¿¡¼­ Á¡Â÷ÀûÀ¸·Î ºÐÇØµÇ°í Á¦°Å ¼ö¼úÀÇ Çʿ伺À» Á¦°ÅÇÏ´Â À¯¸ÁÇÑ À¯ÇüÀÇ Áö°üÀý ÀÓÇöõÆ®ÀÔ´Ï´Ù. ÁßÇÕü ¹× ¼¼¶ó¹Í°ú °°Àº Àç·á·Î ¸¸µé¾îÁø ÀÌ·¯ÇÑ ÀÓÇöõÆ®´Â Á¶Á÷ Àç»ýÀ» ÃËÁøÇϸ鼭 ÀϽÃÀûÀÎ Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. °¨¿° À§ÇèÀ» ÁÙÀ̰í Ä¡À¯¸¦ °³¼±ÇÏ´Â µîÀÇ ÀÌÁ¡À» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿¹Ãø±â°£ µ¿¾È °ñ°üÀý¿° ºÐ¾ß°¡ °¡Àå ³ôÀº CAGR ¿¹»ó.

°ñ°üÀý¿° ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. °ñ°üÀý¿°¿¡¼­ Áö°üÀý ÀÓÇöõÆ®´Â ƯÈ÷ ¼Õ°¡¶ô °üÀýÀÇ ±â´É ȸº¹°ú ÅëÁõÀ» ¿ÏÈ­½Ãŵ´Ï´Ù. º¯Çü¼º °üÀýÁõÀÌ ÁøÇàµÇ¸é ¿¬°ñÀÌ ¿­È­µÇ¾î °üÀýÀÇ ±»¾îÁüÀ̳ª ºÒÄè°¨À¸·Î À̾îÁý´Ï´Ù. Áö°üÀý ÀÓÇöõÆ®´Â °üÀýÀÇ °¡µ¿¼ºÀ» ³ôÀÌ°í ¼ÕÀÇ Àüü ±â´É°ú ȯÀÚ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â ½ÇÇà °¡´ÉÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡, °üÀý¿° ¹× ¼Õ ºÎ»ó°ú °°Àº Áúº´ À¯º´·ü Áõ°¡, ÇコÄɾî ÀÎÇÁ¶ó °³¼±ÀÌ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, ±â¼ú°ú ¼ö¼ú ÀýÂ÷ÀÇ Áøº¸°¡ Ä¡·á ¿É¼ÇÀ» ³ÐÇô ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. Áß±¹, ÀϺ», Àεµ µîÀÇ ±¹°¡µéÀº ȯÀÚ Àα¸°¡ ¸¹°í °Ç°­ °ü¸® ÁöÃâÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ À¯¸®ÇÑ ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

ºÏ¹Ì´Â °í·ÉÈ­ »çȸ¿¡¼­ ¿Ü»ó¼º ¼Õ»ó°ú ÅðÇ༺ °üÀý ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÓÇöõÆ® ±â¼úÀÇ Áøº¸¿Í Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÀÚ±ØÇÕ´Ï´Ù. ¶ÇÇÑ °Ç°­ °ü¸® ÁöÃâ Áõ°¡¿Í ȯÀÚ ÀÇ½Ä Çâ»óÀº ÀÌ Áö¿ªÀÇ Áö¼ÓÀûÀÎ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃã¼³Á¤ ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç ¹× Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : Á¦Ç°º°

  • ½Ç¸®ÄÜ ÀÓÇöõÆ®
  • ÆÄÀÌ·ÎÄ«º» ÀÓÇöõÆ®
  • ±Ý¼Ó ÀÓÇöõÆ®
  • »ýºÐÇØ¼º ÀÓÇöõÆ®
  • ¼¼¶ó¹Í ÀÓÇöõÆ®
  • ±âŸ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : ÀçÁúº°

  • »ýü ÀûÇÕ¼º Àç·á
  • ºñ»ýüÀûÇÕ¼º Àç·á

Á¦7Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : °íÁ¤ ¹æ¹ýº°

  • ½Ã¸àÆ®
  • ½Ã¸àÆ®¸®½º

Á¦8Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : ¼³°èº°

  • ÇØºÎÇÐÀû ¼³°è
  • ¹ÝÁ¦¾à ¼³°è
  • ºñÁ¦¾à ¼³°è

Á¦9Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : ¿¬·É ±×·ìº°

  • ¼Ò¾Æ
  • ¼ºÀÎ
  • °í·ÉÀÚ

Á¦10Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : ¿ëµµº°

  • °ñ°üÀý¿°
  • ·ù¸¶Æ¼½º °üÀý¿°
  • ¿Ü»ó¼º °üÀý¿°
  • ¿Ü»ó¼º °üÀý¿°
  • ±âŸ ¿ëµµ

Á¦11Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • Á¤Çü¿Ü°ú Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦12Àå ¼¼°èÀÇ Áö°üÀý ÀÓÇöõÆ® ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦13Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛÅõÀÚ(JV)
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦14Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Johnson & Johnson Medical Devices Company
  • Wright Medical Group
  • Teijin Nakashima Medical Corporation
  • Smith & Nephew
  • Stryker Corporation
  • Integra Lifesciences
  • Acumed LLC
  • Merete Medical GmbH
  • Zimmer Biomet Holdings Inc.
  • Vilex in Tennessee Inc.
  • Signature Orthopedics Implants
  • Anika Therapeutics
  • Beznoska
  • Skeletal Dynamics
  • in2bones
  • Evolutis
AJY 24.06.21

According to Stratistics MRC, the Global Digit Joint Implants Market is accounted for $72.38 million in 2024 and is expected to reach $124.09 million by 2030 growing at a CAGR of 9.4% during the forecast period. Digit joint implants are prosthetic devices used to replace or augment damaged or dysfunctional finger joints. Typically composed of durable materials like metal or ceramic, these implants mimic the structure and function of natural joints, enabling improved mobility and functionality in the affected digits. By restoring range of motion and stability to the fingers, digit joint implants can enhance quality of life and facilitate activities of daily living for individuals with compromised hand function.

According to the data updated by NCBI in May 2022, it is estimated that osteoarthritis affects about 3.3 to 3.6% of the population globally and it causes moderate to severe disability in 43 million people, making it the 11th most debilitating disease worldwide.

Market Dynamics:

Driver:

Rising prevalence of traumatic injuries

Traumatic injuries, such as those resulting from accidents, sports-related incidents, or occupational hazards, often lead to severe damage to finger joints, necessitating surgical intervention for restoration of function. Digit joint implants offer a viable solution by replacing or repairing damaged joints, enabling patients to regain mobility and dexterity. As traumatic injuries continue to occur, the demand for digit joint implants is expected to increase, driving market growth.

Restraint:

Risk of complications

The risk of complications in digit joint implants arises from various factors such as infection, implant failure, and nerve damage. These complications can lead to prolonged recovery periods, additional surgeries, and decreased patient satisfaction. Such outcomes not only increase healthcare costs but also erode patient confidence in the procedure and the implanted devices. Consequently, it hampers market growth as patients may opt for alternative treatments or delay seeking medical intervention altogether.

Opportunity:

Continuous innovations in material science

Continuous innovations in material science play a pivotal role in propelling the growth of the digit joint implants market. Advancements in materials such as biocompatible metals, ceramics, and biodegradable polymers have led to the development of implants with enhanced durability, biocompatibility, and functionality. These innovations enable surgeons to provide more effective treatment options for patients with digit joint disorders, leading to improved surgical outcomes and patient satisfaction. Moreover, ongoing R&D efforts in material science ensure the creation of next-generation implants, driving further market expansion through improved product offerings and treatment efficacy.

Threat:

Alternative treatment options

Alternative treatment options to digit joint implants include non-surgical approaches like physical therapy, pain management, and lifestyle modifications. While these alternatives may offer temporary relief, they often fail to address the underlying joint damage effectively. Consequently, patients may postpone or avoid surgery altogether, impacting the demand for digit joint implants. Additionally, the preference for non-invasive methods can deter patients from considering surgical interventions, limiting the market potential.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the digit joint implants market. While there has been a surge in demand for orthopedic procedures, including joint replacements, due to postponed surgeries and increased awareness of healthcare needs, there have also been disruptions in the supply chain and challenges in accessing healthcare facilities. Additionally, economic uncertainties and shifting healthcare priorities have influenced patient decisions and healthcare expenditure. Overall, the market has experienced fluctuations in demand and supply dynamics, with both positive and negative impacts attributable to the pandemic.

The biodegradable implants segment is expected to be the largest during the forecast period

The biodegradable implants segment is estimated to have a lucrative growth. Biodegradable implants are a promising type of digit joint implant that gradually degrades within the body over time, eliminating the need for removal surgeries. Made from materials like polymers or ceramics, these implants provide temporary support while promoting tissue regeneration. They offer potential advantages such as reduced risk of infection and improved healing.

The osteoarthritis segment is expected to have the highest CAGR during the forecast period

The osteoarthritis segment is anticipated to witness the highest CAGR growth during the forecast period. In the context of osteoarthritis, digit joint implants offer relief by restoring function and alleviating pain in affected joints, particularly in the fingers. As osteoarthritis progresses, cartilage deteriorate, leading to joint stiffness and discomfort. Digit joint implants provide a viable treatment option, enhancing joint mobility and improving overall hand function and patients' quality of life.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. Rising geriatric population, increasing prevalence of conditions like arthritis and hand injuries, and improving healthcare infrastructure are key drivers. Moreover, advancements in technology and surgical techniques are expanding treatment options and enhancing patient outcomes. Countries such as China, Japan, and India are emerging as lucrative markets due to large patient populations and increasing healthcare spending.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of traumatic injuries and degenerative joint diseases among the aging population. Advancements in implant technology and a growing preference for minimally invasive procedures further stimulate market growth. Further, rising healthcare expenditure and improving patient awareness contribute to sustained market expansion in the region.

Key players in the market

Some of the key players profiled in the Digit Joint Implants Market include Johnson & Johnson Medical Devices Company, Wright Medical Group, Teijin Nakashima Medical Corporation, Smith & Nephew, Stryker Corporation, Integra Lifesciences, Acumed LLC, Merete Medical GmbH, Zimmer Biomet Holdings Inc., Vilex in Tennessee Inc., Signature Orthopedics Implants, Anika Therapeutics, Beznoska, Skeletal Dynamics, in2bones and Evolutis.

Key Developments:

In September 2023, Stryker launched minimally invasive surgical bunion treatment. The new technology features MIS joint preparation, triplanar reduction and a three-screw construct that creates a tension band for biomechanical stability.

In May 2022, CONMED Corporation signed a definitive agreement to acquire privately-held In2Bones Global, Inc. In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. The company's comprehensive product portfolio includes implants, fracture systems, biologics, and related hardware.

Products Covered:

  • Silicone Implants
  • Pyrocarbon Implants
  • Metal Implants
  • Biodegradable Implants
  • Ceramic Implants
  • Other Products

Materials Covered:

  • Biocompatible Materials
  • Non-Biocompatible Materials

Fixations Covered:

  • Cemented
  • Cementless

Designs Covered:

  • Anatomical Design
  • Semi-Constrained Design
  • Unconstrained Design

Age Groups Covered:

  • Pediatric
  • Adult
  • Geriatric

Applications Covered:

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Post-Traumatic Arthritis
  • Other Applications

End Users Covered:

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digit Joint Implants Market, By Product

  • 5.1 Introduction
  • 5.2 Silicone Implants
  • 5.3 Pyrocarbon Implants
  • 5.4 Metal Implants
  • 5.5 Biodegradable Implants
  • 5.6 Ceramic Implants
  • 5.7 Other Products

6 Global Digit Joint Implants Market, By Material

  • 6.1 Introduction
  • 6.2 Biocompatible Materials
  • 6.3 Non-Biocompatible Materials

7 Global Digit Joint Implants Market, By Fixation

  • 7.1 Introduction
  • 7.2 Cemented
  • 7.3 Cementless

8 Global Digit Joint Implants Market, By Design

  • 8.1 Introduction
  • 8.2 Anatomical Design
  • 8.3 Semi-Constrained Design
  • 8.4 Unconstrained Design

9 Global Digit Joint Implants Market, By Age Group

  • 9.1 Introduction
  • 9.2 Pediatric
  • 9.3 Adult
  • 9.4 Geriatric

10 Global Digit Joint Implants Market, By Application

  • 10.1 Introduction
  • 10.2 Osteoarthritis
  • 10.3 Rheumatoid Arthritis
  • 10.4 Traumatic Arthritis
  • 10.5 Post-Traumatic Arthritis
  • 10.6 Other Applications

11 Global Digit Joint Implants Market, By End User

  • 11.1 Introduction
  • 11.2 Hospitals
  • 11.3 Orthopedic Clinics
  • 11.4 Ambulatory Surgical Centers
  • 11.5 Other End Users

12 Global Digit Joint Implants Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Johnson & Johnson Medical Devices Company
  • 14.2 Wright Medical Group
  • 14.3 Teijin Nakashima Medical Corporation
  • 14.4 Smith & Nephew
  • 14.5 Stryker Corporation
  • 14.6 Integra Lifesciences
  • 14.7 Acumed LLC
  • 14.8 Merete Medical GmbH
  • 14.9 Zimmer Biomet Holdings Inc.
  • 14.10 Vilex in Tennessee Inc.
  • 14.11 Signature Orthopedics Implants
  • 14.12 Anika Therapeutics
  • 14.13 Beznoska
  • 14.14 Skeletal Dynamics
  • 14.15 in2bones
  • 14.16 Evolutis
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦